November 08, 2019
Apotex Inc. is recalling a single lot of atorvastatin calcium tablets, 40 mg, after a pravastatin tablet was discovered in a bottle. The recall appeared in the November 6, 2019, US Food and Drug Administration (FDA) Enforcement Report.
Recalled are 1968 bottles of 1000-count atorvastatin calcium tablets (NDC 60505-2580-8) from lot RC5439 (Exp. 3/22). The bottles were distributed in Illinois, Mississippi, New Jersey, Ohio, and Texas.
Apotex voluntarily initiated the recall October 22, 2019. On October 28, 2019, the FDA designated the recall Class III. Under the recall classification, use of the affected tablets is not likely to cause harm.
Both atorvastatin and pravastatin are prescription statins used to treat high cholesterol and triglyceride levels.